Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Genet Metab ; 112(2): 160-70, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24726177

RESUMO

Morquio A (Mucopolysaccharidosis IVA; MPS IVA) is an autosomal recessive lysosomal storage disorder caused by partial or total deficiency of the enzyme galactosamine-6-sulfate sulfatase (GALNS; also known as N-acetylgalactosamine-6-sulfate sulfatase) encoded by the GALNS gene. Patients who inherit two mutated GALNS gene alleles have a decreased ability to degrade the glycosaminoglycans (GAGs) keratan sulfate and chondroitin 6-sulfate, thereby causing GAG accumulation within lysosomes and consequently pleiotropic disease. GALNS mutations occur throughout the gene and many mutations are identified only in single patients or families, causing difficulties both in mutation detection and interpretation. In this study, molecular analysis of 163 patients with Morquio A identified 99 unique mutations in the GALNS gene believed to negatively impact GALNS protein function, of which 39 are previously unpublished, together with 26 single-nucleotide polymorphisms. Recommendations for the molecular testing of patients, clear reporting of sequence findings, and interpretation of sequencing data are provided.


Assuntos
Condroitina Sulfatases/genética , Condroitina Sulfatases/metabolismo , Mucopolissacaridose IV/genética , Mutação , Células Cultivadas , Criança , Pré-Escolar , Feminino , Estudos de Associação Genética , Testes Genéticos , Genótipo , Glicosaminoglicanos/metabolismo , Humanos , Lactente , Lisossomos/metabolismo , Masculino , Mucopolissacaridose IV/diagnóstico , Polimorfismo de Nucleotídeo Único
2.
Mol Genet Metab ; 111(2): 133-8, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24125893

RESUMO

In this study, 103 unrelated South-American patients with mucopolysaccharidosis type II (MPS II) were investigated aiming at the identification of iduronate-2-sulfatase (IDS) disease causing mutations and the possibility of some insights on the genotype-phenotype correlation The strategy used for genotyping involved the identification of the previously reported inversion/disruption of the IDS gene by PCR and screening for other mutations by PCR/SSCP. The exons with altered mobility on SSCP were sequenced, as well as all the exons of patients with no SSCP alteration. By using this strategy, we were able to find the pathogenic mutation in all patients. Alterations such as inversion/disruption and partial/total deletions of the IDS gene were found in 20/103 (19%) patients. Small insertions/deletions/indels (<22 bp) and point mutations were identified in 83/103 (88%) patients, including 30 novel mutations; except for a higher frequency of small duplications in relation to small deletions, the frequencies of major and minor alterations found in our sample are in accordance with those described in the literature.


Assuntos
Éxons , Iduronato Sulfatase/genética , Mucopolissacaridose II/genética , Mutação , Adulto , Feminino , Estudos de Associação Genética , Técnicas de Genotipagem , Humanos , Mucopolissacaridose II/diagnóstico , Mucopolissacaridose II/patologia , Análise de Sequência de DNA , Índice de Gravidade de Doença , América do Sul
3.
Transl Psychiatry ; 2: e195, 2012 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-23168995

RESUMO

Adverse early-life environment is associated with anxiety-like behaviors and disorders. Brain-derived neurotrophic factor (BDNF) is sensitive to this environment and could be a marker of underlying brain changes. We aimed at evaluating the development of anxiety-like behaviors in a rat model of early adversity, as well as the possible association with BDNF levels. Similar associations were investigated in a sample of adolescent humans. For the rat study, Wistar rat litters were divided into: early-life stress (ELS, limited access to nesting material) and control groups. Maternal behavior was observed from days 1 to 9 of life and, as adults, rats were subjected to behavioral testing and BDNF measurements in plasma, hippocampus, amygdala and periaqueductal gray. For the human study, 129 adolescents were evaluated for anxiety symptoms and perceived parental care. Serum BDNF levels and the Val66Met polymorphism of the BDNF gene were investigated. We found that ELS dams showed more pure contact, that is, contact with low care and high control, toward pups, and their adult offspring demonstrated higher anxiety-like behaviors and plasma BDNF. Also the pure contact correlated positively with adult peripheral BDNF. Similarly in humans, there was a positive correlation between maternal overprotection and serum BDNF only in Met carriers. We also found negative correlations between maternal warmth and separation anxiety, social phobia and school phobia. Finally, our translational approach revealed that ELS, mediated through variations in maternal care, is associated with anxiety in both rats and humans and increased peripheral BDNF may be marking these phenomena.


Assuntos
Ansiedade , Fator Neurotrófico Derivado do Encéfalo/sangue , Comportamento Materno/psicologia , Estresse Psicológico/sangue , Adolescente , Animais , Ansiedade/sangue , Ansiedade/genética , Ansiedade/psicologia , Fator Neurotrófico Derivado do Encéfalo/genética , Criança , Modelos Animais de Doenças , Feminino , Humanos , Masculino , Polimorfismo de Nucleotídeo Único , Ratos , Estresse Psicológico/genética
4.
JIMD Rep ; 4: 125-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23430907

RESUMO

Hunter syndrome, or Mucopolysaccharidosis type II (MPS II), is a rare X-linked recessive disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). The phenotypic spectrum varies from severe to attenuated clinical forms. We report a large Brazilian family with 16 affected individuals exhibiting a very attenuated form of MPS II. Fourteen female carriers were also identified. Twelve affected male patients, whose ages ranged from 1 to 35 years, were examined. Molecular analysis showed a novel missense mutation (p.A77D) in the IDS gene, confirming the diagnosis. Nine of the family members presented some degree of heart damage, though only the proband became symptomatic and required heart transplantation. One 19-year-old adult and 1-year-old twin boys each had a normal echocardiogram. Short stature was found in two adults while macrocephaly was found in one; the remaining adults had anthropometric measures within normal range. All affected adults had normal cognitive development and were able to perform normal daily activities, except one who had mild learning disability. Two patients died due to natural causes beyond 70 years of age. The female carriers did not present any signs of disease. In this large family with a mild form of MPS II and variable degree of clinical manifestations, it is noteworthy that several affected individuals have remained asymptomatic even at advanced age and even without enzyme replacement therapy.

5.
J Inherit Metab Dis ; 32(6): 732-738, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19821143

RESUMO

The aim of the study was to characterize clinically and biochemically mucopolysaccharidosis type II (MPS II) heterozygotes. Fifty-two women at risk to be a carrier, with a mean age of 34.1 years (range 16-57 years), were evaluated through pedigree analysis, medical history, physical examination, measurement of iduronate sulfatase (IDS) activities in plasma and in leukocytes, quantification of glycosaminoglycans (GAGs) in urine, and analysis of the IDS gene. Eligibility criteria for the study also included being 16 years of age or older and being enrolled in a genetic counselling programme. The pedigree and DNA analyses allowed the identification of 40/52 carriers and 12/52 non-carriers. All women evaluated were clinically healthy, and their levels of urinary GAGs were within normal limits. Median plasma and leukocyte IDS activities found among carriers were significantly lower than the values found for non-carriers; there was, however, an overlap between carriers' and non-carriers' values. Our data suggests that MPS II carriers show lower plasma and leukocyte IDS activities but that this reduction is generally associated neither with changes in levels of urinary GAGs nor with the occurrence of clinical manifestations.


Assuntos
Heterozigoto , Mucopolissacaridose II/genética , Adolescente , Adulto , Biomarcadores/análise , Biomarcadores/urina , Estudos de Casos e Controles , Análise Mutacional de DNA , Família , Saúde da Família , Feminino , Glicoproteínas/análise , Glicoproteínas/genética , Glicosaminoglicanos/análise , Glicosaminoglicanos/urina , Humanos , Pessoa de Meia-Idade , Mucopolissacaridose II/diagnóstico , Mucopolissacaridose II/urina , Linhagem , Exame Físico , Adulto Jovem
6.
J Inherit Metab Dis ; 28(6): 1027-34, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16435196

RESUMO

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome, MPS VI) is an autosomal recessive disorder caused by deficiency of N-acetylgalactosamine-4-sulphatase (ARSB),which leads to the lysosomal accumulation and excretion of dermatan sulphate (DS). In this study, 13 unrelated MPS VI patients (12 Brazilian and 1 Chilean) were investigated regarding the identification of the ARSB gene mutations using PCR, SSCP and sequencing. The exons with altered mobility on SSCP were sequenced, as well as all the exons of patients with no SSCP alteration. Seven novel mutations were identified: D59N, L72R, Q88H, P93S, R197X, 1279delA and c.1143-8T > G. The previously reported mutations 1533del23, R315Q and 427delG were found in six, three and two alleles respectively. The other mutations already reported, S384N and G144R, were found in only one allele. In addition, three polymorphisms previously described (V358M, V376M and P397P) were detected in the patients analysed. Our findings are in agreement with the literature confirming the great genetic heterogeneity associated with MPS VI.


Assuntos
Mucopolissacaridose VI/enzimologia , Mucopolissacaridose VI/genética , Mutação , N-Acetilgalactosamina-4-Sulfatase/genética , Adolescente , Adulto , Alelos , Criança , Pré-Escolar , Condroitina Sulfatases/genética , Análise Mutacional de DNA , Éxons , Variação Genética , Humanos , Lactente , Mutação Puntual , Reação em Cadeia da Polimerase , Polimorfismo Genético , Polimorfismo Conformacional de Fita Simples , Análise de Sequência de DNA , América do Sul
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...